EDGAR Filing Documents for 0001193125-15-233674

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001193125-15-233674

Filing Date

2015-06-25

Accepted

2015-06-24 19:11:56

Documents

Period of Report

2015-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	FROM 10-Q	d923077d10q.htm	10-Q	430979
2	EX10_16	d923077dex1016.htm	EX-10.16	10709
3	EX-31.1	d923077dex311.htm	EX-31.1	8722
4	EX-31.2	d923077dex312.htm	EX-31.2	8767
5	EX-32.1	d923077dex321.htm	EX-32.1	3982
6	EX-32.2	d923077dex322.htm	EX-32.2	3985
13	GRAPHIC	g923077g38n78.jpg	GRAPHIC	7591
	Complete submission text file	0001193125-15-233674.txt		2753447

Data Files

Seq	Description	Document	Type	Size
7	XBRL INSTANCE DOCUMENT	rkda-20150331.xml	EX-101.INS	315401
8	XBRL TAXONOMY EXTENSION SCHEMA	rkda-20150331.xsd	EX-101.SCH	35513
9	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	rkda-20150331_cal.xml	EX-101.CAL	56613
10	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	rkda-20150331_def.xml	EX-101.DEF	142008
11	XBRL TAXONOMY EXTENSION LABEL LINKBASE	rkda-20150331_lab.xml	EX-101.LAB	322978
12	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	rkda-20150331_pre.xml	EX-101.PRE	226309

Mailing Address 4222 E. THOMAS RD SUITE 245 PHOENIX X1 85018

Business Address 202 COUSTEAU PLACE SUITE 200 DAVIS X1 95618 602-429-0476

Arcadia Biosciences, Inc. (Filer) CIK: 0001469443 (see all company filings)